Answers are grounded in this paper and cite their sources.
This analysis reveals a connection between biochemical processes and disease forms in streptococcal quinsy, suggesting ximedon for optimizing therapy.
The metabolic enzyme systems of acetylation and microsomal oxidation were studied in patients with streptococcal quinsy. A relationship was found between the clinical forms of the disease and the specific features of biochemical processes in the organism. There was evidence that the pyrimidine drug ximedon should be incorporated into combination therapy for quinsy to regulate metabolic processes, by taking into account the phenotypes of acetylation and oxidation and the forms of the disease.
No takes yet. Share an insight, caveat, or question.
Kravchenko et al. (2011) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: